Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/01/2003US20030083240 Bactericides
05/01/2003US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation
05/01/2003US20030083238 Cyclic hexapeptide derivatives
05/01/2003US20030083236 Myelopeptides and their therapeutic use
05/01/2003US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy
05/01/2003US20030082769 Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082579 Generating library of preferential polypeptides; obtain nucleotide sequences, incubate with primers, amplify, recover amplification product, transform and express sequence incell, monitor and evaluate cell activity
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082510 Treatment for viral or bacterial infections of blood; obtain blood sample, incubate with test compound, expose to light, evaluate sample for presence active pathogen
05/01/2003US20030082234 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
05/01/2003US20030082213 Use of microparticles combined with submicron oil-in-water emulsions
05/01/2003US20030082211 Polysaccharide antigen in carrier
05/01/2003US20030082210 Sequence determination; calibration
05/01/2003US20030082207 Method of using HIV protease inhibiting compounds
05/01/2003US20030082204 Mixture of attenuated genetic engineered virus and carrier
05/01/2003US20030082200 Protein binding to immobilized vitronectin
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082112 Alkyl hydroxybenzoate in an oral care composition with an alkaline pH
05/01/2003US20030082107 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
05/01/2003CA2793019A1 Humanized antibodies
05/01/2003CA2498591A1 Immunotherapy for reversing immune suppression
05/01/2003CA2470197A1 Mycobacterial genes down-regulated during latency
05/01/2003CA2464609A1 Use of egf to inhibit pathogenic infections of the urogenital tract
05/01/2003CA2464396A1 Method for screening agent acting on cell wall
05/01/2003CA2464366A1 A method for identification and development of therapeutic agents
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
05/01/2003CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003CA2463282A1 Therapeutical agent for pruritus
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2463043A1 Combination of liponic acid and glutamine in food and pharmaceutical products
05/01/2003CA2462163A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
05/01/2003CA2461182A1 Use of tyrosine kinase inhibitors for promoting hair growth
05/01/2003CA2461181A1 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
05/01/2003CA2458958A1 Method and apparatus for dispensing inhalator medicament
05/01/2003CA2454361A1 Humanized antibodies
05/01/2003CA2429505A1 Prevention of recurrent viral disease
04/2003
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1414964A Antibacterial heterobicyclic substituted phenyl oxazolidinones
04/30/2003CN1414951A Drug discharge pump inhibitors
04/30/2003CN1414864A Adhesive particle DNA constructs and method of making and using the same
04/30/2003CN1414863A Treatment of DNA viral infections
04/30/2003CN1414861A Induction of mucosal immunity by vaccination via skin nute
04/30/2003CN1414859A Combinations for treatment of DNA viral infections
04/30/2003CN1414857A Treatment of drug-resistant human immunodeficiency virus infection
04/30/2003CN1414854A Phosphonate compounds
04/30/2003CN1414846A Topical anti-microbial compositions
04/30/2003CN1414016A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414015A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414014A Leptospira adventitial protein its code sequence and use
04/30/2003CN1413730A Shugan injection and its preparation technology
04/30/2003CN1413727A Composite medicine for radical curing AIDS
04/30/2003CN1413713A Chinese medicine preparation for auxiliary treating virus hepaptitis
04/30/2003CN1413705A Granule for treating hepatopathy
04/30/2003CN1413693A Drug for treating cold
04/30/2003CN1413686A Medicine for treating respiratory tract system disease caused by cold
04/30/2003CN1413663A Capsule for positive of hepatitis B transformation to negative
04/30/2003CN1413662A Decoction for positive reaction of hepatitis B transformation to negative
04/30/2003CN1413647A Chinese medicine preparation for radical curing AIDS
04/30/2003CN1413642A Method for extracting chrysanthemum medicinal component and extract
04/30/2003CN1413626A Pill for treating hepatitis B
04/30/2003CN1413620A Shugan Zhitong soft extract for treating hepatitis
04/30/2003CN1413612A Miehening soft extract and powder and its preparation technology
04/30/2003CN1413606A Medicine for treatment of hepatitis
04/30/2003CN1413602A Chinese medicine prescription for treatment of appendicitis
04/30/2003CN1413586A Long-acting antiseptic injection for animal
04/30/2003CN1413585A Sodium penicillin for skin test
04/30/2003CN1107115C System for expression of heterologous antigens as fusion proteins
04/30/2003CN1107068C 2-amino-7-(1-substituted-2-hyroxyethyl)-3.5-diphydro-pyrrolo (3,2-D) pyrimidine-4-ones
04/30/2003CN1107067C Carbapenem compounds, use and intermediate compounds thereof
04/30/2003CN1107058C Subsitituted isoxazoles for treatment of inflammation
04/29/2003US6555710 Aminobenzophenones as inhibitors of IL-1 β and TNF-α
04/29/2003US6555693 Compounds that affect the expression of genes essential for the proliferation of the pathogen; promoters or gene expression inhibition; binding to double-stranded DNA; fungicides; bactericides; viricides
04/29/2003US6555676 Antitumor agents
04/29/2003US6555569 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
04/29/2003US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue
04/29/2003US6555559 5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same
04/29/2003US6555558 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
04/29/2003US6555545 Adenosine, caffeine, and 8-styryl-1,3,7-alkyl xanthine derivatives as wound healing agents
04/29/2003US6555543 Inhibiting the effects of platelet activating factor (PAF).
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555524 Ketolide antibiotics
04/29/2003US6555523 Use of cirsiliol and derivatives to treat infections
04/29/2003US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases
04/29/2003US6555346 Selecting a recombinant baculovirus expressing the protein, growing insect cells in a culture vessel and infecting the cells with an inoculum of baculovirus at a cell density of 1 x 105-5 x 106 cells/ml
04/29/2003US6555338 Given nucleotide sequence; use of polynucleotides and polypeptides in diagnostic assays, and possibly functional genomics
04/29/2003US6555331 Bacteriophage assay
04/29/2003US6555136 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
04/29/2003US6555133 Oral dosage
04/29/2003US6555132 Soft gelatin capsule manufacture
04/29/2003US6555114 Immunodominant human T-cell epitopes of hepatitis C virus
04/29/2003CA2098105C Oligoside derived from an antigen polyoside obtained from a pathogen
04/29/2003CA2095855C Mycobacterium as adjuvant for antigens
1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 1798